< Back to scientific publications

Magazine 9.06

Use of Plerixafor in Predicted and Proven Poor Mobilizer (according to GITMO criteria). Experience of Policlinico Universitario Tor Vergata”

Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., .Giannì L, Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M..

Date: 2012

Scope of interest: Haematology




You may also be interested in:

Magazine 14.17

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First ItalianζoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy


Read details
Report/Poster of Convention/Congress Act

Sars -cov 2 epidemiology , therapy ,prevention

Authors: ilaria uccella

Date: 2020

Scope of interest: infectious disease training programs


Read details
Report/Poster of Convention/Congress Act

” Objectives achieved and future challenges”

Authors: ilaria uccella

Date: 2019

Scope of interest: infectious disease training programs


Read details